Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial. [electronic resource]
Producer: 20060823Description: 149-54 p. digitalISSN:- 1097-6744
- Aged
- Angina, Unstable -- drug therapy
- Angioplasty, Balloon, Coronary
- Anticoagulants -- economics
- Antithrombins -- economics
- Combined Modality Therapy
- Drug Therapy, Combination
- Female
- Heparin -- economics
- Hirudins -- economics
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- drug therapy
- Peptide Fragments -- economics
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Randomized Controlled Trials as Topic
- Recombinant Proteins -- economics
- Syndrome
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.